2015
Pan, Christopher C, et al. “Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy.”. J Biol Chem, vol. 290, no. 24, Jan. 2015, pp. 14884-92, https://doi.org/10.1074/jbc.M114.630178.
Jandova, J, et al. “Fn14 Receptor Promotes Invasive Potential and Metastatic Capacity of Non-Small Lung Adenocarcinoma Cells through the Up-Regulation of Integrin α6.”. Neoplasma, vol. 62, no. 1, Jan. 2015, pp. 41-52.
Samulitis, Betty K, et al. “Gemcitabine Resistant Pancreatic Cancer Cell Lines Acquire an Invasive Phenotype With Collateral Hypersensitivity to Histone Deacetylase Inhibitors.”. Cancer Biol Ther, vol. 16, no. 1, Jan. 2015, pp. 43-51, https://doi.org/10.4161/15384047.2014.986967.
Lee, Yeon Sun, et al. “Modification of Amphipathic Non-Opioid Dynorphin A Analogues for Rat Brain Bradykinin Receptors.”. Bioorg Med Chem Lett, vol. 25, no. 1, Jan. 2015, pp. 30-3, https://doi.org/10.1016/j.bmcl.2014.11.026.
Majuta, Lisa A, et al. “Orthopedic Surgery and Bone Fracture Pain Are Both Significantly Attenuated by Sustained Blockade of Nerve Growth Factor.”. Pain, vol. 156, no. 1, Jan. 2015, pp. 157-65, https://doi.org/10.1016/j.pain.0000000000000017.
Espeland, Mark A, et al. “Postmenopausal Hormone Therapy, Type 2 Diabetes Mellitus, and Brain Volumes.”. Neurology, vol. 85, no. 13, Jan. 2015, pp. 1131-8, https://doi.org/10.1212/WNL.0000000000001816.
Frankowski, Kevin J, et al. “Potency Enhancement of the κ-Opioid Receptor Antagonist Probe ML140 through Sulfonamide Constraint Utilizing a Tetrahydroisoquinoline Motif.”. Bioorg Med Chem, vol. 23, no. 14, Jan. 2015, pp. 3948-56, https://doi.org/10.1016/j.bmc.2014.12.033.
Kim, Ji-Young V, et al. “Spinal Dopaminergic Projections Control the Transition to Pathological Pain Plasticity via a D1 D5-Mediated Mechanism.”. J Neurosci, vol. 35, no. 16, Jan. 2015, pp. 6307-17, https://doi.org/10.1523/JNEUROSCI.3481-14.2015.
Caldwell, Charles C, et al. “Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities.”. Neurotherapeutics, vol. 12, no. 1, Jan. 2015, pp. 66-80, https://doi.org/10.1007/s13311-014-0324-8.
Ronaldson, Patrick T, and Davis, Thomas P. “Targeting Transporters: Promoting Blood-Brain Barrier Repair in Response to Oxidative Stress Injury.”. Brain Res, vol. 1623, Jan. 2015, pp. 39-52, https://doi.org/10.1016/j.brainres.2015.03.018.
Fawley, Jessica A, et al. “Temperature Differentially Facilitates Spontaneous But Not Evoked Glutamate Release from Cranial Visceral Primary Afferents.”. PLoS One, vol. 10, no. 5, Jan. 2015, p. e0127764, https://doi.org/10.1371/journal.pone.0127764.
Stevenson, Glenn W, et al. “The Mixed-Action Delta Mu Opioid Agonist MMP-2200 Does Not Produce Conditioned Place Preference But Does Maintain Drug Self-Administration in Rats, and Induces in Vitro Markers of Tolerance and Dependence.”. Pharmacol Biochem Behav, vol. 132, Jan. 2015, pp. 49-55, https://doi.org/10.1016/j.pbb.2015.02.022.
Slosky, Lauren M, and Vanderah, Todd W. “Therapeutic Potential of Peroxynitrite Decomposition Catalysts: A Patent Review.”. Expert Opin Ther Pat, Jan. 2015, pp. 1-24, https://doi.org/10.1517/13543776.2014.1000862.
Slosky, Lauren M, et al. “Use of Animal Models in Understanding Cancer-Induced Bone Pain.”. Cancer Growth Metastasis, vol. 8, no. Suppl 1, Jan. 2015, pp. 47-62, https://doi.org/10.4137/CGM.S21215.
2014
Grenald, Shaness A, et al. “Animal Models for Opioid Addiction Drug Discovery.”. Expert Opin Drug Discov, vol. 9, no. 11, Nov. 2014, pp. 1345-54, https://doi.org/10.1517/17460441.2014.966076.
Hegarty, Deborah M, et al. “Capsaicin-Responsive Corneal Afferents Do Not Contain TRPV1 at Their Central Terminals in Trigeminal Nucleus Caudalis in Rats.”. J Chem Neuroanat, vol. 61-62, Nov. 2014, pp. 1-12, https://doi.org/10.1016/j.jchemneu.2014.06.006.
Sancheti, Harsh, et al. “Hypermetabolic State in the 7-Month-Old Triple Transgenic Mouse Model of Alzheimer’s Disease and the Effect of Lipoic Acid: A 13C-NMR Study.”. J Cereb Blood Flow Metab, vol. 34, no. 11, Nov. 2014, pp. 1749-60, https://doi.org/10.1038/jcbfm.2014.137.
Bannister, Kirsty, et al. “Neuropathic Plasticity in the Opioid and Non-Opioid Actions of Dynorphin A Fragments and Their Interactions With Bradykinin B2 Receptors on Neuronal Activity in the Rat Spinal Cord.”. Neuropharmacology, vol. 85, Oct. 2014, pp. 375-83, https://doi.org/10.1016/j.neuropharm.2014.06.005.
Thompson, Brandon J, et al. “Hypoxia/Reoxygenation/Stress/Signals/an/Increase/in/Organic/Anion/Transporting/Polypeptide/1a4/(Oatp1a4)/at/the/Blood-Brain/Barrier:/Relevance/to/CNS/Drug/Delivery.”. J Cereb Blood Flow Metab, vol. 34, no. 4, Apr. 2014, pp. 699-07, https://doi.org/10.1038/jcbfm.2014.4.
Sancheti, Harsh, et al. “Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer’s Disease: A 13C NMR Study.”. J Cereb Blood Flow Metab, vol. 34, no. 2, Feb. 2014, pp. 288-96, https://doi.org/10.1038/jcbfm.2013.196.
Kumar, S, et al. “Antibody-Directed Coupling of Endoglin and MMP-14 Is a Key Mechanism for Endoglin Shedding and Deregulation of TGF-β Signaling.”. Oncogene, vol. 33, no. 30, Jan. 2014, pp. 3970-9, https://doi.org/10.1038/onc.2013.386.
Zhang, Yan, et al. “Behavioral and Cellular Pharmacology Characterization of 17-Cyclopropylmethyl-3,14β-Dihydroxy-4,5α-Epoxy-6α-(isoquinoline-3’-Carboxamido)morphinan (NAQ) As a Mu Opioid Receptor Selective Ligand.”. Eur J Pharmacol, vol. 736, Jan. 2014, pp. 124-30, https://doi.org/10.1016/j.ejphar.2014.04.041.
Moutal, Aubin, et al. “Differential Neuroprotective Potential of CRMP2 Peptide Aptamers Conjugated to Cationic, Hydrophobic, and Amphipathic Cell Penetrating Peptides.”. Front Cell Neurosci, vol. 8, Jan. 2014, p. 471, https://doi.org/10.3389/fncel.2014.00471.
Wilson, Sarah M, et al. “Differential Regulation of Collapsin Response Mediator Protein 2 (CRMP2) Phosphorylation by GSK3ß and CDK5 Following Traumatic Brain Injury.”. Front Cell Neurosci, vol. 8, Jan. 2014, p. 135, https://doi.org/10.3389/fncel.2014.00135.
Lee, Yeon Sun, et al. “Discovery of Amphipathic Dynorphin A Analogues to Inhibit the Neuroexcitatory Effects of Dynorphin A through Bradykinin Receptors in the Spinal Cord.”. J Am Chem Soc, vol. 136, no. 18, Jan. 2014, pp. 6608-16, https://doi.org/10.1021/ja501677q.